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Abstract
The revolutionary development of nanoscience during the last years has increased the
number of studies in the field to evaluate the toxicity and risk levels. The design of
different nanomaterials together with biological components has implemented the
advances in biomedicine. Specifically, nanoparticles seem to be a promising platform
due to their features, including nanoscale dimensions and physical and chemical
characteristics than can be modified in function of the final application. Herein, we
review the main studies realized with nanoparticles in order to understand and
characterize the cellular uptake mechanisms involved in biocompatibility, toxicity,
and how they alter the biological processes to avoid disease progression.
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1. Introduction
The nanoscience revolution that sprouted throughout the 1990s is becoming part of our daily
life in the form of cosmetics, food packaging, drug delivery systems, therapeutics, or biosen‐
sors, among others [1]. It has been estimated that the production of nanomaterials would
increase in 2020 by 25 times what it is today.
This is due to the wide range of applications that they have in numerous fields, ranging from
commercial products such as electronic components, cosmetics, household appliances,
semiconductor devices, energy sources, food color additives, surface coatings, and medical
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products such as biological sensors, drug carriers, biological probes, implants, and medical
imaging. Despite this future dependence on nanomaterials, studies regarding their safe
incorporation in our lives are very limited [2].
Recently, several studies suggested that nanoparticles (NPs) could easily enter into the human
body [3]. This is mainly because their nanoscale dimensions are of a similar size to typical
cellular components. Moreover, proteins–NPs may bypass natural mechanical barriers,
possibly leading to adverse tissue reactions. As a result, the particles might be taken up into
cells. Generally, NPs of different physical and chemical properties may enter the cells by
different mechanisms, such as phagocytosis, macropinocytosis, endocytosis, or directly by
“adhesive interactions” [4].
In order to understand the exact cellular influences of NPs, a thorough characterization of
individual nanoparticles is necessary. Nanoparticles can get into the human body through
various ways, such as skin penetration, inhalation, or injection, and due to their small size and
diffusion abilities; they have the potential to interact with cells and organs. In addition to
involuntary exposure to NPs by means of contacting nanomaterials-based products, there are
cases where nanoparticles would interact with the human body for biomedical purposes.
In case of using nanoparticles for targeted-drug delivery, NPs are required to traverse the cell
membranes and interact with specific components. Hence, the success rate of drug delivery is
based on the biocompatibility of NPs. Research has shown that different physicochemical
properties of NPs result in different cellular uptake. Currently, it has been described that
several factors play a critical role in toxicity (Fig. 1); such as (i) size and surface, very important
for liposomes, silicon microparticles, quantum dots, polymeric NPs, or gold NPs; (ii) concen‐
tration, crystallinity, and mechanical strength, toxicity is directly related to these parameters
[2]; (iii) chemical attributes, the development of hydrophilic polymer functionalization (i.e.
polyethylene glycol, polycarboxybetaine) at the surface of NPs enhances the systemic circu‐
lation; however, the response of the immune system is also related with this hydrophilic
coating.
The discovery of Enhanced Permeation and Retention (EPR) effect and its combination with
hydrophilic polymers is related to the accumulation of NP-based carrier systems in tumor
tissues followed by the release of the drug either in the proximity to the tissue. However, EPR
effect is commonly inconsistent due to the heterogeneity associated with the tumor tissue. For
this reason, novel nanomedicines are being designed and developed in order to target only a
particular cell, tissue, and organ by linking an affinity reagent to the NP, which is targeting a
specific biomolecule differentially expressed at the tissue or cells of interest.
Although some concerns have been raised about poor systemic circulation, enhanced clearance
by the mononuclear phagocyte system and limited tissue penetration has been shown to
improve the cellular uptake and efficacy of their payload in comparison with passively
targeted counterparts. This improvement in cellular uptake is a key point because mostly of
the targets present intracellular location. Bearing this in mind, the characterization of endo‐
cytosis pathways plays a critical role in designing efficient intracellular trafficking, subcellular
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targeting, and nanomedicines with ideal features (biocompatibility, low-toxicity, and low-
immune response) [4].
Herein, we present a comprehensive review on recent developments and outline future
strategies of nanotechnology-based medicines. Specifically, the trials in vivo/in vitro, requested
by The National Cancer Institute, that evaluate NP toxicity for nanomedicines are detailed
below. They can be sorted in two large groups: biocompatibility and immunological studies.
Figure 1. Effects of nanomaterials on cells.
2. Biocompatibility studies
Once the NPs are in biological environment, it is expected that their interaction with biomo‐
lecules, such as proteins, lipids, nucleic acids, and even metabolites, is to a large extent because
of their high surface-to-mass ratio. Bearing in mind that proteins are one of the majority
components in biological fluids, formation of a protein corona at the surface of NPs is expected.
This protein corona may substantially influence the biological response [5].
2.1. Relation of biomolecular corona and nanoparticles toxicity
Herein, we briefly describe how this biomolecular corona influences mainly in cellular uptake,
toxicity, and biodistribution and targeting ability to a lesser extent.
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2.1.1. Effect of physicochemical properties
2.1.1.1. Size
The size of nanomaterials has a direct and significant impact on the physiological activity. In
fact, the NP size may be expanded by the biomolecular corona. Then, the NP size plays a critical
role in cellular uptake, efficiency of particle processing in the endocytic pathway, and phys‐
iological response of cells to NPs. Kim and collaborators [6] thoroughly studied the size-
dependent cellular toxicity of Ag NPs using different characteristic sizes against several cell
lines, including MC3T3-E1 and PC12. They demonstrated that NP toxicity was precisely size-
and dose-dependent in terms of cell viability, intracellular reactive oxygen species generations,
LDH release, and ultra-structural changes in the cell.
In general, biodegradable NPs are less cytotoxic than non-biodegradable ones [7]. Apart from
the nature of NP coating, particle size can also affect the degradation of the polymer matrix.
With the decrease of particle size, the surface area-to-volume ratio increases greatly, leading
to an easier penetration and release of the polymer degradation products. Even though it can
be assumed that the smaller the NP size, the more likely it can enter into cells and cause
potential damages, the mechanisms of toxicity are very complicated, so the size factor cannot
be viewed as the only influence parameters.
Yuan and collaborators studied the effect of size of hydroxyapatite NPs on the antitumor
activity and apoptotic signaling proteins. They studied the effect of particle size on cell
apoptosis, the Hep62 cells (incubated with and without hydroxyapaptite NPs), presented
morphological changes related to apoptosis which were related to the size of the NPs [8].
2.1.1.2. Nanomaterial and shape
The structure and shape influence in the toxicity of nanomaterials (Fig. 2). Commonly,
nanomaterials have different shapes and structures such as tubes, fibers, spheres, and planes.
For instance, several studies compared cytotoxicity of multi-wall carbon nanotubes vs. single-
wall carbon nanotubes or graphene [9, 10], obtaining results that suggest a strong influence of
the shape and toxicity. Furthermore, other authors have evaluated the toxicity of nanocarbon
materials vs. NPs [11].
2.1.1.3. Concentration of nanomaterial
In 2013, a research was carried out to inspect the cytotoxicity of a cisplatin derivative, known
as PtU2. Minor toxicity was detected when this compound was conjugated with 20 nm gold
NPs (Au-NPs). Cisplatin is one of the most used anticancer agents and its conjugation with
Au-NPs gives it benefits thanks to Au characteristics: biocompatibility, inactivity, non-toxicity,
and stability. In this way, the compound becomes a powerful tool for the treatment of solid
tumors. In the present trial, osteosarcoma cell line (MG-63) was treated with different concen‐
trations of AuNPs, PtU2 and a combination of both, PtU2-AuNPs. Firstly, one of the aims was
the determination of the carrier activity. In order to achieve this, the metal content (gold and
platinum) was measured in cells and supernatants separately. The results showed that metal
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uptake capacity from cells is the same for AuNPs or AuNPs conjugated with PtU2. Then, the
cytotoxicity was evaluated by Annexin V-FITC assay by flow cytometry. As a result of MG-63
incubation with the two compounds, higher cytotoxicity was detectable after 48 hours of
culture in cells treated with PtU2-AuNPs. To sum up, PtU2-AuNPs are more effective inciting
cellular toxicity on the same culture conditions [12].
2.2. Relation of biomolecular corona and cellular uptake
Due to protein nature of the biomolecular corona, it is important to distinguish between
specific and nonspecific cellular uptake. Specific uptake is regulated by membrane receptors
that are internalized by interaction with specific ligands. In turn, nonspecific uptake is
considered a random process without control by the cell [5].
Overall, nonspecific uptake seems to be decreased in the presence of a corona whereas specific
uptake seems to be promoted by protein corona because a misfolding of corona proteins
triggers NPs uptake by specific cells that otherwise would not have done so or because there
is a protein in the corona able to target a specific receptor expressed in the cell line used. So
far, all the performed studies suggest how important cell line specificity is for this protein
corona effect. However, a more extensive revision of literatures is recommended because in
many occasions some inconsistencies of cellular uptake of NPs have been found, particularly
regarding incubation conditions or fluidic For example, several studies for cellular uptake of
differential macrophage-like cell line (dTHP1) have different outcomes. In such a way, Yan
and colleagues [13] did not observe any changes in effective association and internalization in
the presence of serum. However, these cells present phagocytosis activity when unfolded BSA
is presented in the protein corona; in this case, phagocytosis is mediated by Scavenger receptor
subclass A.
Figure 2. Characteristics and studies about the nanomaterials effect. Adapted from Li X. et al. [2].
Evaluation Strategies of Nanomaterials Toxicity
http://dx.doi.org/10.5772/60733
27
2.3. Effect of protein corona on biodistribution
Despite the knowledge about the influence of NP PEGylation on biodistribution, the charac‐
terization and consequences of a biomolecular corona formed in vivo has not been investigated
yet.
Hence, it has been described that, independently of the nature of the NPs, pre-coating with
proteins, such as serum albumin, or apolipoprotein E, increases the blood circulation time and
reduces the clearance speed. This effect is explained by a reduction in opsonization and
phagocytosis; meanwhile, liver is the main organ for NP accumulation and the protein used
for pre-coating seems to be distributed in other organs (i.e. albumin targeting and apolipo‐
protein E target lungs and brain, respectively) [14].
2.4. Different assays for evaluation of cytotoxicity/biocompatibility
In general, the mechanisms of toxicity are very complicated. Several studies have been
developed for biological characterization of nanomaterials which are vital to guarantee the
safety of the material that will be in contact with food or humans. Here, a brief description of
the most conventional assays to evaluate cytotoxicity/biocompatibility is reported.
2.4.1. Cytotoxicity analysis
In order to determine the viability of cells exposed to NPs, toxicity tests in vitro are very useful
to understand the toxic mechanisms [2]. Some of these tests are listed: Alamar Blue Assay,
MTT, LDH leakage assay [2, 15], and quick cell [16]. First and second approaches constitute
an index of intrinsic cytotoxicity.
On the one hand, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide assay
(mitochondrial toxicity, MTT, assay) is based on the transformation of tetrazolium salt by
mithocondrial succinate dehydrogenases in metabolically active cells generating purple
formazan crystals [17]. This oxidation–reduction reaction can be only produced in presence of
dehydrogenase enzymes, so it is a good way to determine the activity of mitochondria [2].
Thus, the number of living cells is proportional to the amount of formazan produced.
Cells with culture medium and NPs are seeded in 96-well plates and then 20 µL/well of MTT,
with a final concentration of 5 mg/mL added to each well. This compound must be incubated
for 4 h at 37ºC and 5% CO2. After the incubation, the solution is removed and the crystals that
have been formed are dissolved by DMSO. Finally, the optical density is measured at 595 nm
expressing the percent cell viability [3, 17]. This method also allows the measurement of cell
survival and proliferation.
Although MTT is the most accepted assay method [2], there is another test to evaluate the
nanotoxicity, the resazurin assay (Alamar Blue, AB, assay). This study is based on the reduction
of blue, nonfluorescent resazurin to pink, fluorescent resorufin by living cells [18]. This
reduction is mediated by mitochondrial enzymes located in the mitochondria, cytosol, and
microsomal fractions [17, 18]. The decrease in the magnitude of resazurin reduction indicates
loss of cell viability.
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The AB assay is commonly used with a final concentration of 10% (w /v). Then, plates are
exposed to an excitation wavelength of 530 nm and emission at 590 nm to determine if any of
the dyes interact with the compound. Lastly, the fluorescence is read 5 hours later and the
percent viability is calculated [17]. Moreover, AB assay has many advantages: it is a simple,
rapid and versatile test and reveals a high correlation with other methods to evaluate nano‐
toxicity [18].
Sometimes, problems with interference between NPs and this type of assay arise [17], so care
must be taken with the dyes used. The confidence degree of toxicity studies significantly
depends on this interaction. Few researchers have found that carbon nanotubes can interact
with dyes such as AB and neutral red [2].
According to the analysis carried out by Hamid R and collaborators, AB assay and MTT are
advisable to identify the cytotoxic compound. However, the AB assay is homogenous and
presents more sensitivity that can detect densities as low as 200 cells per well [17].
In turn, cell death is also determined by evaluating the activity of the enzyme lactate dehy‐
drogenase (LDH). LDH is an enzyme generally located in the cytosol, but it is quickly released
when cellular damage is produced. In this way, the LDH release assay allows the assessment
of the membrane integrity of cells by measuring this enzyme in the extracellular medium. This
method, like MTT, uses the measure of a color compound absorbance to determine the cell
viability that can be affected by the uptake of NPs [19].
The Quick Cell Proliferation Colorimetric Assay Kit works in a similar way. This is based on
the cleavage of the tetrazolium salt to formazan by mitochondrial dehydrogenases. An increase
in the activity of these enzymes is connected with cellular proliferation. The formazan dye
produced by viable cells can be quantified by a spectrophotometer by measuring the absorb‐
ance of the solution at 440 nm. Moreover, the Quick Cell Assay has several advantages in face
of MTT because it is a new simple method, requiring no washing, no harvesting, and no
solubilization steps, and it is more sensitive and faster too [20].
2.4.2. Assays for studying cell death by effects of nanomaterials
The cytotoxicity analysis can be complemented by other studies. Here, we present different
methods to determine cell death or apoptosis, including trypan blue (TB) and propidium
iodide (PI) protocols.
TB exclusion test marks which cells are viable. This is because live cells have intact cell
membranes and certain dyes, such as TB or PI, cannot entry into them [21]. In dead cells, the
membrane is ruptured and the dye is able to cross it and stain the cytoplasm of blue. In 2014,
Mendes and colleagues [22] published a work where their aim was to investigate different
diameters of iron oxide NPs. Four cell lines were incubated with NPs to assess the material
toxicity and the possible size dependence. Cell viability was measured using the MTT and TB
tests. For the dye exclusion assay, the cells were seeded in 6-well flat-bottom plates and
incubated for 12 or 48 h with a NP suspension at 10 µg/mL concentration. Then, 20 µL of each
suspension was mixed with 0.4% TB to count the number of living and dead cells. This method
was used because with the MTT it was not clear if NPs caused cell death or whether they only
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reduced the cellular metabolic activity. The results showed that cells incubated with the
carbon-coated iron oxide NPs tend to decrease their mitochondrial activity (indicated by MTT
test) rather than die (indicated by the dye exclusion test). In conclusion, cytotoxicity analysis
showed no apparent difference between the diameters studied, whereas there are clear
differences in particle uptake.
On the other hand, Alshatwi and collaborators [23] have published a work where the toxicity
of platinum NPs is evaluated. The objective in this project is to investigate the effects of
platinum NPs on cell viability, nuclear morphology, and cell cycle distribution on SiHa cells
(a cervical cancer cell line). To study the nuclear morphology, SiHa cells were incubated with
platinum NPs for 24 hours. Then, cell nucleus were stained by 1mg/mL PI and examined under
a fluorescence inverted microscope. In treated cells, nuclear fragmentation, chromatin
condensation, and nuclear swelling were observed. The nuclear fragmentation is a hallmark
of late apoptosis.
In the same way, PI was also used to determine the cell cycle stage of treated cells by a flow
cytometer. The results showed that these NPs induced a G2/M phase cell cycle arrest due to
DNA damage. Briefly, this investigation suggests that platinum NPs inhibit cell proliferation
because they induce cell death via apoptosis. Moreover, the NPs also have effect by reducing
cell viability and causing DNA fragmentation and G2/M cell cycle arrest. That is why; they can
be a potential therapy agent in the cervical cancer treatment.
Secondly, we describe two different ways to evaluate the cell death induced by apoptosis.
Apoptosis or program cell death occurs in the normal physiology during development and
aging to keep a balance between proliferation and cell death [24, 25]. It is also a defense
mechanism and it is important for removing damaged cells and decreasing the damage on
neighbor cells.
This process is carried out by loss of the mitochondrial transmembrane potential and activation
of caspases (cysteine proteases). These proteins can be categorized into initiators (caspases 2,
8, 9, 10), effectors (caspases 3, 6, 7), and inflammatory caspases (caspases 1, 4, 5) [24].
Frequently, cell apoptosis is usually evaluated using a caspase-3 activation assay. For instance,
Xun et al. put into effect a work where they tried to study the effect of silica NP size (7, 20, and
50 nm) on cytotoxicity. The cell line HepG2, a human hepatoma model, was selected for the
study. HepG2 cells were treated with silica NPs of 20 nm (SNP20) at concentrations of 160 µg/
mL and 320 µg/mL for 24 and 48 hours, respectively. Then, caspase-3 assay buffer and
caspase-3 lysis buffer were added into the cell culture. After reaction, the fluorescence intensity
was detected under a fluorescence plate reader. Caspase-3 is an essential molecule in the final
phase of apoptosis induced by diverse stimulus. Results obtained in this analysis showed an
increase of caspase-3 activity about 2–3 fold higher in cells treated with SNP20 than that of
controls after 24 hours of incubation and about 3–5 fold after 48 hours. About this evidence,
silica NPs could activate caspase-3 and downregulate procaspase-9, indicating an activation
of caspase-9 in HepG2 cells. That is, these NPs can change apoptotic protein expression and
greatly increase apoptosis in mitochondria-dependent pathways in hepatoma cells. In
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addition, Annexin V-FITC/PI assay was used in this study to quantify cell apoptosis. This test
allows distinguishing between normal, apoptotic, and necrotic cells.
HepG2 cells and normal L-02 hepatic cell lines exposed to SNP20, at the same two concentra‐
tion used before, were stained using Annexin V-FITC and PI and analyzed by flow cytometry.
Apoptotic cells undergo changes in the distribution of their membrane lipids. Phosphatidyl‐
serine is a phospholipid commonly presented inside the membrane, whereas during apoptosis,
processes are expressed on the cellular surface.
In this way, Annexin V, which has a high affinity for phosphatidylserine, is used as a marker
of early apoptosis. However, PI is used to distinguish necrotic cells from apoptotic cells. This
is an agent which is intercalated in the DNA of dead cells when losing the membrane integrity.
As a result, almost no apoptotic cells were detected in controls and treated L-02 cells and in
control HepG2 cells. On the contrary, many apoptotic cells were found in HepG2 treated with
SNP20, indicating that apoptosis induced by NPs is dose-dependent [25].
Annexin V is a method commonly used for assessing cellular apoptosis. For example, Ashok‐
kumar and collaborators as well as Grudzinski et al. employed this procedure in their studies.
In the first one, the aim was to evaluate whether gold NPs are able to induce apoptosis in cancer
cells. HepG2 cell line was used for the investigation and these were treated for 24 hours with
gold NPs. After that, cells were stained with Annexin V and the level of apoptosis was
quantified as a percentage of Annexin V positive cells. Finally, the results showed that HepG2
treated with gold NPs undergo cell apoptosis whereas untreated cells did not show it [26]. In
the second investigation, they tried to study the cytotoxicity of carbon-encapsulated iron
nanoparticles (CEIN) in murine glioma cells (GL261). These cells were divided into two groups:
one was treated at two different concentrations during 24 hours, whereas the other group was
the control group (untreated cells). Then, both groups were stained with Annexin V and the
analysis was performed by flow cytometer. The results indicated that the samples treated with
the higher concentration of CEIN induced some pro-apoptotic and necrotic events in the
glioma cell line. As a summary, this work have supposed a huge progress because it is the first
report which clearly displays that CEINs with surface modifications with acidic groups cause
murine glioma cell-specific cytotoxicity [27].
3. Immunological studies
Besides the fact that NPs play an important role in medicine area and their properties can be
used to improve traditional treatments and diagnostic agents [28], there are many biocompat‐
ibility studies about size, shape, charge, solubility, and surface modification of NPs. However,
the interphase related to interactions between NPs and immune system is still not well
understood.
According to literature, NPs can activate and/or suppress immune response and the compat‐
ibility with this system is determined by its surface chemistry. Therefore, NPs can be designed
to avoid immunotoxicity and reach desirable immunomodulation [29, 30].
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Preclinical data shows that NPs are not more immunotoxic than conventional drugs, so NPs
employed like drug carriers can provide advantages, such as the reduction of systemic
immunotoxicity. For instance, NPs can release the drug in a specific tissue in order to not alter
safe tissues and they may keep drugs away from blood cells. Moreover, NPs can also decrease
drug immunotoxicity by raising their solubility. However, NPs are generally picked up by
phagocytic cells of the immune system, such as macrophages. This incident can produce
immunostimulation or immunosuppression, which may promote inflammatory or autoim‐
mune disorders. For example, granuloma formation was observed in the lungs and skin of
animals treated with carbon nanotubes [29].
Next, we briefly describe immunostimulation and immunosuppression linked to NPs uptake.
3.1. Immunosuppression
There are not many studies about this area for NPs because most of the researches focused on
the inflammatory properties of NPs [29].
One of the studies about immunosuppression has revealed that inhalation of carbon nanotube
(CNT) results in a reduction of immune system in mice. This is produced through a mechanism
that involves the release of TFG-β1 from lungs. Then, TFG-β1 goes into circulation and
increases the expression of two molecules whose function is to inhibit T-cell proliferation [31].
Other NPs that can produce immunosuppression are zinc oxide (ZnO) particles. They are able
to induce immunosuppression in vitro and in vivo in function of the different size and charge.
ZnO NPs suppress innate immunity such as natural killer cell activity. Moreover, the
CD4+/CD8+ ratio, a marker for matured T-cells, serum levels of T helper-1 cytokines (interferon-
γ and IL-12p70) and pro/anti-inflammatory were slightly reduced. In the opposite sense, no
significant changes were detected in T- and B-cell proliferation [32].
3.2. Immunostimulation
Biological therapeutics, where NPs are included, are able to activate the immune system. In
other words, nanomaterials are identified by this system and innate or adaptive immune
responses are produced. We briefly describe several effects of NPs on cytokine secretion,
immunogenicity and the mechanism through which nanoparticles are recognized by the
immune system.
On the one hand, many immunostimulatory reactions, driven by NPs, are mediated by the
release of inflammatory cytokines. Cytokines are signaling molecules inducted by different
types of nanomaterials: gold, dendrimers, or lipid nanoparticles, among others. Moreover, NP
size is an important factor for determining whether antigens loaded into NPs stimulate type I
(interferon-γ) or II (IL-4) [29, 30]. For example, a study carried out from peripheral blood
mononuclear cells of non-atopic women showed that palladium NPs improved the release of
IFN-γ [33]. In other study about THP1-macrophages, the results showed that chitosan-DNA
nanoparticles did not produce pro-inflammatory cytokines, whereas the secretion of metallo‐
proteinase 9 and 2 was increased in cell supernatants [34].
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This kind of analysis is often evaluated by enzyme-linked immunosorbent assay (ELISA).
Antibodies and an enzyme-mediated color change are used to determine the presence and
relative concentrations of particular cytokines present in the tissue or cell culture media. [35,
36]. ELISA is based on the concept of an antigen binding to its specific antibody, which allows
identification of small quantities of molecules such as cytokines [36].
In turn, NPs induce antibody response (immunogenicity). NPs raise a special interest in this
area because immunogenicity is improved by stimulating the production of antibodies [30].
Plasma B cells are responsible for making antibodies, specialized proteins, in response to an
antigen [29].
A recent in vivo study about a novel dengue nanovaccine (DNV) has demonstrated that the
vaccine can stimulate humoral and cell-mediated immune responses. This vaccine is composed
by the dengue virus type 2 inactivated. Moreover, the adjuvant chitosan together with NPs
including cell wall components from Mycobacterium bovis were used to improve the action of
the DNV. Mice treated with this compound showed an increase of cytokine levels and a strong
anti-dengue IgM and IgG antibody response. The release of IFN-γ produced by CD4+ and
CD8+ T cell was also incremented. In conclusion, these results demonstrated that the DNV can
be an important vaccine candidate for treatment of dengue disease [37].
Finally, we briefly mention the mechanism through which NPs are phagocyted into the cells.
Macrophages are responsible for the first line of defense in the organism. They detect and
uptake foreign molecules and synthesize mediators which warn the immune system about
infection. Raw 264.7, a mouse leukemic monocyte macrophages cell line, is the model line used
for the phagocytosis assays. For instance, Raw 264.7 was utilized in a new in vitro research
about the effect of silica and gold NPs in macrophages. The results showed that silica and gold
NPs decreased the ability of phagocytosis in 50%, while surface markers and cytokine secretion
were not disturbed due to the particles [38]. To evaluate this analysis, different methods can
be used depending on the composition of the nanomaterial. These procedures include confocal
microscopy, optical and fluorescence microscopy, transmission electron microscopy (TEM),
or scanning electron microscopy (SEM) [38, 39].
4. Conclusions and perspectives
Bearing in mind the importance and relevancy of the NPs in biomedical field, a better under‐
standing of their effects on the human body is therefore required. According to the points
described above, the physicochemical properties of nanomaterials play a critical role in
toxicity. Thus, the alteration of these properties could be used to modify the toxicity and/or
biocompatibility of these materials. On the other side, it is also necessary to obtain the
maximum amount information about the interaction of biological interactions of NPs with
cells, tissues, and proteins. In fact, this could be a critical parameter for the future application
of nanomaterials in the biomedical area. In this review, special attention has been paid to the
protein corona because it plays a critical role in toxicity and biocompatibility. Many studies
have been performed; however, further studies are needed to know how to exploit the benefits
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of the corona in vivo; mainly, because it seems quite complicated to predict the composition of
proteins corona and its biological consequences.
Despite immense progress on the evaluation of toxicity and biocompatibility of nanomaterials,
from this comprehensive review it is pointed out that further experimentation is still ongoing
in this field to obtain a better and optimal understanding of the interaction between nanoma‐
terials and the human body.
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